Literature DB >> 26239594

Comparable effect of partly supervised and self-administered exercise programme in early rheumatoid arthritis--a randomised, controlled trial.

Trine Seneca1, Ellen Margrethe Hauge, Thomas Maribo.   

Abstract

INTRODUCTION: There is a need to establish a framework and exercise level for patients with early rheumatoid arthritis (RA). The aim of this study was to compare the effect of a partly supervised and a self-administered exercise programme for patients with early RA.
METHODS: A total of 51 patients with early (≤ 5 years) RA were randomised to either a six-week supervised, progressive, high-intensity exercise programme followed by a six-week self-administered exercise programme or a 12-week self-administered exercise programme.
RESULTS: A total of 36 patients completed the study. Following the 12 weeks of exercises, patients in the two groups had improved both their muscle strength and their physical fitness. There was a significant difference in Disease Activity Score in 28 joints calculated with C-reactive protein between the two exercise groups, but no significant differences in physical fitness, pain perception, Health Assessment Questionnaire, Short Form 36 health survey questionnaire, Fear-Avoidance Beliefs Questionnaire, or in muscle strength, except from a significant difference in trunk extensors. The dropout was 40% in the supervised group versus 20% in the self-administered group.
CONCLUSION: A progressive, high-intensity exercise programme is feasible for patients with early RA, although we observed an elevated number of dropouts for reasons not related to the intervention. The partly supervised exercise programme with follow-up after 12 weeks does not seem to be more effective than the self-administered exercise programme. FUNDING: none. TRIAL REGISTRATION: The trial was registered with www.clinicaltrials.gov (NCT01553305).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239594

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  5 in total

Review 1.  Exercise for rheumatoid arthritis of the hand.

Authors:  Mark A Williams; Cynthia Srikesavan; Peter J Heine; Julie Bruce; Lucie Brosseau; Nicolette Hoxey-Thomas; Sarah E Lamb
Journal:  Cochrane Database Syst Rev       Date:  2018-07-31

2.  Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis.

Authors:  Theodora P M Vliet Vlieland; Karin Niedermann; Anne-Kathrin Rausch Osthoff; Carsten Bogh Juhl; Keegan Knittle; Hanne Dagfinrud; Emalie Hurkmans; Juergen Braun; Jan Schoones
Journal:  RMD Open       Date:  2018-12-04

Review 3.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03

4.  Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.

Authors:  Andréa Marques; Eduardo Santos; Elena Nikiphorou; Ailsa Bosworth; Loreto Carmona
Journal:  RMD Open       Date:  2021-05

5.  A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis.

Authors:  Graham Boniface; Varsha Gandhi; Meriel Norris; Esther Williamson; Shona Kirtley; Neil E O'Connell
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.